Cannabinoids hurt, heal in cirrhosis

Nature Medicine

Volumn 12, Issue 6, 2006, Pages 608-610

  Kunos, George ^a   Osei Hyiaman, Douglas ^a   Bátkai, Sándor ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; RIMONABANT;

ANXIETY DISORDER; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FIBROGENESIS; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SHORT SURVEY;

ANIMALS; CELL COMMUNICATION; CLINICAL TRIALS; ENDOCANNABINOIDS; FIBROSIS; HUMANS; LIVER CIRRHOSIS; RECEPTOR, CANNABINOID, CB1;

CANNABIS SATIVA;

EID: 33745020449     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0606-608     Document Type: Short Survey

References (15)

1. Friedman, S.L. Nat. Clin. Pract. Gastr. Hepatol. 1, 98-105 (2004).
2. Teixeira-Clerc, F. et al. Nat. Med. 12, 671-676 (2006).
3. Howlett, A.C. et al. Neuropharmacol. 47 (Suppl. 1), 345-358 (2004).
4. Julien, B. et al. Gastroenterology 128, 742-755 (2005).
5. Hézode, C. et al. Hepatology 42, 63-71 (2005).
6. Siegmund, S.V. et al. Hepatology 41, 983-995 (2005).
7. Bátkai, S. et al. Nat. Med. 7, 827-832 (2001).
8. Ros, J. et al. Gastroenterology 122, 85-93 (2002).
9. Gaskari, S.A. et al. Br. J. Pharmacol. 146, 315-323 (2005).
10. Osei-Hyiaman, D. et al. J. Clin. Invest. 115, 1298-1305 (2005).
11. Farrell, G.C. & Larter, C.Z. Hepatology 43, S99-S112 (2006).
12. Després, J.P. et al. N. Engl. J. Med. 353, 2121-2134 (2005).
13. Ikejima, K. et al. Gastroenterology 122, 1399-1410 (2002).
14. Kamada, Y. et al. Gastroenterology 125, 1796-1807 (2003).
15. Friedman, S.L. & Bansal, M.B Hepatology 43, S82-S88 (2006).